MOLKENTIN MICHAEL 4
4 · Astex Pharmaceuticals, Inc · Filed Dec 10, 2012
Insider Transaction Report
Form 4
MOLKENTIN MICHAEL
Chief Financial Officer
Transactions
- Award
Employee Stock Option (Right to buy)
2012-12-06+160,000→ 160,000 totalExercise: $2.71Exp: 2022-12-06→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]Grant to reporting person of option to purchase shares of Common Stock under the Issuer's 2003 Stock Plan. The option vests and becomes exercisable as to 1/48th of the shares on January 6, 2013 and at the end of each full month thereafter.